Skip to content
★ Sign in to follow
OC

Occitan Capital Management Inc.

Shareholder
Related company / holding
Alexza Pharmaceuticals Inc.
Total declarations
50
Company
1
▲ Purchases (47 ops.)
€190k
▼ Sales (3 ops.)
€12k

Latest filing published 20 Jan 2012 for Alexza Pharmaceuticals Inc., €2,792.

Insider track record

Disclosed buys
47
Disclosed sells
3
Signal history

No signal scores available.

Closed purchases

Market purchases
47

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Occitan Capital Management Inc.: trading record in brief

Occitan Capital Management Inc. discloses dealings in Alexza Pharmaceuticals Inc. to SEC (Form 4). We count 50 filings; the first trade dates from 23 December 2011 and the latest from 13 January 2012.

In open-market terms, that means 47 purchases worth €190k on one side and 3 sales worth €12k on the other. The net balance comes to €177k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2012 to date brings 47 purchases and 3 sales.

In size, the median ticket on the buying side is €2,009.

The newest entry dates from 20 January 2012: an open-market purchase of €72, in Alexza Pharmaceuticals Inc. Typically, a trade is published a median of 10 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Occitan Capital Management Inc.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations43 total

25 of 43 declarations